Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus (Q37115724)

18 August 2017

1 reference

title

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

1 reference

David G Marrero

1

1 reference

18 August 2017

1 January 2007

1 reference

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

2

1 reference

18 August 2017

33-40; discussion 41-3

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

The underuse of insulin therapy in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Insulin treatment reverses the insulin resistance of type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

The burden of treatment failure in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Standards of medical care in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Healthy lifestyle characteristics among adults in the United States, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Predictors of adherence with antihypertensive and lipid-lowering therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

A systematic review of adherence with medications for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Self-management support for insulin therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2960006-5

7 January 2021

10.1016/S1098-3597(09)60006-5

Identifiers

DOI

1 reference

release_wpfb3xor6rbknaqcsn4uxxtrbq

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wpfb3xor6rbknaqcsn4uxxtrbq

24 November 2022

mapped directly with Wikidata item

PubMed ID

18357954

1 reference

PubMed ID

18357954